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Activation of mGluR2 is known to induce analgesic
effect in animal pain models. mGluRs have been found
in trigeminal ganglia and dura of rats.
Our aim was to examine effect of mGlu2 PAMS in
facial allodynia model induced by partial ligation of
infraorbital nerve (pIONL) in rats.
The two selective mGlu2 PAM compounds studied,
JNJ-40068782 (JNJ), and Compound A (CA) of G.Richter
have high in vitro potency with functional EC50 values
on human mGlu2R of 8 nM and 39 nM, respectively.
Allodynia was measured by von Frey filaments at least
ten days after pIONL. Gabapentin, a drug used in neu-
ropathic pain, and sumatriptan, an anti-migraine drug
significantly reduced allodynia.
Single p.o. dosing of CA produced dose-dependent
reversal of allodynia with ED50 = 1.7 mg/kg and maxi-
mum effect of 92% at 10 mg/kg dose. In a 7-day repeated
dose study with 0.5 mg/kg dose, a sustained, significant
effect was seen. Similarly, no sign of tolerance was seen
with 10-day repeated administration of JNJ at 30 mg/kg
p.o. dose, selected based on acute dose-response study.
Potential side effects of both compounds were moni-
tored by an automated behavioral observation system. In
the above examined dose range and dosing regimens
(acute and chronic) no considerable side effects were
detected. No effect of CA on thermal or mechanical
nociceptive threshold was seen up to 10 mg/kg dose.
Our results suggest potential utility of mGluR2 PAMs
against trigeminal neuralgia or migraine. CA proved to
be similarly effective but much more potent in vivo
than JNJ.
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